ATE234622T1 - Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen - Google Patents

Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Info

Publication number
ATE234622T1
ATE234622T1 AT96943630T AT96943630T ATE234622T1 AT E234622 T1 ATE234622 T1 AT E234622T1 AT 96943630 T AT96943630 T AT 96943630T AT 96943630 T AT96943630 T AT 96943630T AT E234622 T1 ATE234622 T1 AT E234622T1
Authority
AT
Austria
Prior art keywords
immunogenic
blood cells
red blood
plates
containing non
Prior art date
Application number
AT96943630T
Other languages
English (en)
Inventor
Sherrill J Slichter
Original Assignee
Puget Sound Blood Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puget Sound Blood Ct filed Critical Puget Sound Blood Ct
Application granted granted Critical
Publication of ATE234622T1 publication Critical patent/ATE234622T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96943630T 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen ATE234622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56684795A 1995-12-04 1995-12-04
PCT/US1996/019467 WO1997020570A1 (en) 1995-12-04 1996-12-04 Non-immunogenic and toleragenic platelet and red blood cell compositions

Publications (1)

Publication Number Publication Date
ATE234622T1 true ATE234622T1 (de) 2003-04-15

Family

ID=24264638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943630T ATE234622T1 (de) 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Country Status (7)

Country Link
EP (1) EP0874635B1 (de)
JP (1) JP2000503631A (de)
AT (1) ATE234622T1 (de)
AU (1) AU725669B2 (de)
CA (1) CA2239574A1 (de)
DE (1) DE69626853T2 (de)
WO (1) WO1997020570A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
PT2768942T (pt) 2011-10-17 2020-01-21 Massachusetts Inst Technology Entrega intracelular
KR102243597B1 (ko) 2013-08-16 2021-04-26 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
KR20170074235A (ko) 2014-10-31 2017-06-29 메사추세츠 인스티튜트 오브 테크놀로지 면역 세포로의 생체분자의 전달
CN107002089B (zh) 2014-11-14 2021-09-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
KR20170102319A (ko) * 2014-12-31 2017-09-08 안트로제네시스 코포레이션 혈소판을 분리하는 방법
CN107250373A (zh) 2015-01-12 2017-10-13 麻省理工学院 通过微流体递送实现的基因编辑
AU2016289530B2 (en) 2015-07-09 2021-05-06 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
EP3344575B1 (de) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intrazelluläres einbringen von biomolekülen in zellen mit einer zellwand

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714524A (en) * 1980-07-02 1982-01-25 Asahi Chem Ind Co Ltd Preparation of dispersion of platelet
JPS5762222A (en) * 1980-10-03 1982-04-15 Asahi Chem Ind Co Ltd Preparation of concentrated solution of platelet, its device and part
WO1987000053A1 (en) * 1985-07-05 1987-01-15 Slichter Sherrill J Method of reducing immunogenicity and inducing immunologic tolerance
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
ATE193454T1 (de) * 1989-09-12 2000-06-15 Pall Corp Verfahren und vorrichtung zur behandlung von menschlichem blut für die transfusion
DE4129516C2 (de) * 1991-09-06 2000-03-09 Fresenius Ag Verfahren und Vorrichtung zum Trennen von Blut in seine Bestandteile

Also Published As

Publication number Publication date
EP0874635B1 (de) 2003-03-19
AU1282597A (en) 1997-06-27
EP0874635A1 (de) 1998-11-04
DE69626853D1 (de) 2003-04-24
WO1997020570A1 (en) 1997-06-12
JP2000503631A (ja) 2000-03-28
CA2239574A1 (en) 1997-06-12
AU725669B2 (en) 2000-10-19
DE69626853T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE3161494D1 (en) Cosmetic preparations
DE69620877D1 (de) Arzneimittelformulierungen für il-12
EP1049459A4 (de) Orale flüssige zusammensetzungen
ATE106740T1 (de) Herstellung von t-zellen und t-zellmembranen, verwendbar zur verhütung und behandlung von autoimmunkrankheiten.
NO960743L (no) Cellulære preparater, deres fremstilling og terapeutiske anvendelse
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
ES2147720T3 (es) Factor de celulas madre.
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
BR8802492A (pt) Composicao esterilizante e de alto grau desinfetante,inodora
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE234622T1 (de) Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen
FI953193L (fi) Uudet (tia) sykloalkyyli (b) indoliyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
MXPA94001321A (es) Funcion y actividad de la proteina viral r.
GB9825096D0 (en) Cells,culture methods and their uses
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
DK161384C (da) Pyrazolooe3,4,5-klaaacridinforbindelser og farmaceutiske praeparater indeholdende saadanne forbindelser
EP0261648A3 (en) Cell membrane proteins, compositions containing them and procedure for their preparation
EP0723454A4 (de) Für die immun- und cns-therapir nutzbare, neuartige tripeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties